Dynavax Technologies Corporation revenue breakdown overview

Dynavax Technologies Corporation revenue for the last year amounted to 232.28 M USD, the most of which — 232.28 M USD — came from its highest performing source at the moment, Innovative Vaccines, the year earlier bringing 722.68 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Dynavax Technologies Corporation 230.94 M USD, and the year before that — 133.77 M USD.